Anti-SGPG(HNK-1) Monoclonal Antibody1vial

(R)-3-((2S,4S,5R)-4-Hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-3,4,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol, 95+%, 25mg

4'-Formyl-[1,1'-biphenyl]-2-carbonitrile, 97%, 10g

Methyl 2-Amino-1,3-thiazole-4-carboxylate, 99.00%, 1g

6-(Benzyloxy)-7-methoxyquinazolin-4(1H)-one, 95.0%, 5g

5-Bromo-2-methoxyphenylacetic acid, 98.0%, 5g

6-Oxopiperidine-3-carboxylic acid, 95.0%, 2.5g

4-Fluoro-3-methylthiophenol, 97.0%, 250mg

N-Bromosuccinimide>98.0%(T)100g

METHYL 2-AMINO-5-CYANO-3-METHYLBENZOATE, 95.0%, 5g

5-(2,3-dihydro-1,4-benzodioxin-6-ylmethyl)-1,3,4-oxadiazol-2-amine, 95.0%, 500mg

(2R,5R)-5-benzyl-3-methyl-2-(5-methylfuran-2-yl)imidazolidin-4-one, 97%, 1g

2-Methyl-1-phenylpropan-1-ol, 95.0%, 100g